End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.018 AUD | +12.50% | +20.00% | -10.00% |
30/04 | Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024 | |
10/04 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.00% | 12.62M | |
+31.44% | 695B | |
+26.51% | 568B | |
-4.67% | 361B | |
+19.67% | 330B | |
+3.74% | 283B | |
+16.68% | 239B | |
+8.57% | 204B | |
-7.53% | 198B | |
+9.20% | 168B |
- Stock Market
- Equities
- SNT Stock
- News Syntara Limited
- Pharmaxis Doses First Patient in Phase Two Sleep Trial